Related Experiment Video
Updated: Jun 29, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
FOXP2 inhibits the aggressiveness of lung cancer cells by blocking TGFβ signaling
Wenya Su1, Song Hu1, Lin Zhou1
1Department of Respiratory and Critical Care Medicine, Changzhou First People's Hospital, Changzhou, Jiangsu 213000, P.R. China.
Abstract:
Lung cancer is associated with high morbidity and mortality rates. Forkhead box P2 (FOXP2) functions as an antitumor gene in various cancers. However, its role in lung cancer remains to be elucidated. The present study explored the potential role of FOXP2 in lung cancer. mRNA levels and protein expression were determined using RT-qPCR and western blotting, respectively. Functional analysis was performed using the CCK-8, Transwell and TUNEL assays. FOXP2 expression was downregulated in lung cancer. Notably, FOXP2 suppressed the proliferative, migratory and invasive abilities of lung cancer cells and promoted tumor cell apoptosis. In addition, FOXP2 blocked TGFβ signaling. However, SRI-011381-stimulated activation of TGFβ signaling reversed the effects of overexpressed FOXP2 and promoted the aggressiveness of lung cancer cells. FOXP2 functions as an antitumor gene in lung cancer cells. FOXP2 suppressed the malignant behavior of lung cancer by inactivating TGFβ signaling.
Insights
Forkhead box P2 (FOXP2) acts as an antitumor gene in lung cancer, suppressing cell proliferation and migration. Inactivating TGF-beta signaling is key to FOXP2
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Lung cancer presents significant morbidity and mortality.
- Forkhead box P2 (FOXP2) exhibits antitumor properties in several cancers.
- The specific role of FOXP2 in lung cancer pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the function of FOXP2 in lung cancer.
- To determine the impact of FOXP2 on lung cancer cell behavior.
- To elucidate the molecular mechanisms underlying FOXP2's role in lung cancer.
Main Methods:
- Quantitative reverse transcription PCR (RT-qPCR) for mRNA levels.
- Western blotting for protein expression analysis.
- Cell Counting Kit-8 (CCK-8), Transwell, and TUNEL assays for functional assessments.
Main Results:
- FOXP2 expression was found to be downregulated in lung cancer tissues.
- Overexpression of FOXP2 inhibited lung cancer cell proliferation, migration, and invasion.
- FOXP2 promoted apoptosis in lung cancer cells and inactivated TGF-beta signaling.
Conclusions:
- FOXP2 functions as a tumor suppressor gene in lung cancer.
- FOXP2 mitigates malignant behaviors in lung cancer by inhibiting TGF-beta signaling.
- Targeting FOXP2 or TGF-beta signaling may offer therapeutic strategies for lung cancer.
Related Concept Videos
Abnormal Proliferation
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply
Targeted Cancer Therapies
There are several types of targeted therapies against...

